Physician profile
Jack P Chen
NPI 1821082389
$18,311.13
in general payments reported to CMS, 2019-2025
41 companies · $4,836 in 2025
The $4,836 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $566 · 2021: $1,618 · 2022: $1,789 · 2023: $4,418 · 2024: $3,709 · 2025: $4,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,471 · Consulting Fee: $2,520 · Travel and Lodging: $1,972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,471.17 |
| Consulting Fee | $2,520.00 |
| Travel and Lodging | $1,972.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $3,689.31 | 2019-2025 | |
| Shockwave Medical, INC | $2,487.39 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,672.68 | 2019-2025 | Watchman Access System, Avvigo Guidance System, Watchman Flx |
| Abbott Laboratories | $1,494.93 | 2019-2023 | Cardiomems |
| Penumbra, INC. | $1,362.18 | 2023-2024 | Indigo System, Penumbra System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,182.55 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $837.88 | 2020-2025 | Wainua, Farxiga |
| Amgen INC. | $714.70 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $698.88 | 2019-2025 | Camzyos, Eliquis |
| Abiomed | $604.48 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $517.53 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $511.49 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $319.31 | 2020-2025 | Sapien 3 Ultra Resilia |
| Medtronic, INC. | $202.52 | 2022-2023 | Micra |
| Heartflow, INC. | $188.67 | 2023-2025 | Ffrct |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.